Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
330.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.20 (0.364%)
Market Cap: £1.75b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Interim 2020 Dividend/Enhanced Script Correction

16 Dec 2020 12:00

RNS Number : 8736I
Hammerson PLC
16 December 2020
 

Hammerson plc (the 'Company')

16 December 2020

 

Interim 2020 Dividend and Enhanced Scrip Dividend Alternative - Correction

 

The following amendment has been made to the Interim 2020 Dividend and Enhanced Scrip Dividend Alternative announcement released on 8 December 2020 at 13:15 under RNS No 9480H.

 

Therefore, 225,830,124 New Shares will be admitted to trading on the London Stock Exchange and the Johannesburg Stock Exchange, rather than 189,816,827 New Shares admitted to trading on the London Stock Exchange and 36,013,297 New Shares admitted to trading on the Johannesburg Stock Exchange, as stated in the main body of the announcement.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Hammerson plc

 

Interim 2020 Dividend and Enhanced Scrip Dividend Alternative

 

16 December 2020

 

Further to the announcement of the Interim 2020 Dividend and the Enhanced Scrip Dividend Alternative on 11 November 2020, the Board of Hammerson plc (the Company) announced that valid elections to participate in the Enhanced Scrip Dividend Alternative were received from Shareholders holding 3,108,216,704 Shares. Accordingly, the number of New Shares to be issued under the Enhanced Scrip Dividend Alternative is 225,830,124.

 

Therefore, 225,830,124 New Shares will be admitted to trading on the London Stock Exchange and the Johannesburg Stock Exchange, bringing the total number of issued 5 pence ordinary shares in the Company to 4,057,298,174.

 

The New Shares are expected to be issued and admitted to trading on the Main Market of the London Stock Exchange and the Johannesburg Stock Exchange on 18 December 2020. A further announcement will be released to confirm when those New Shares have been issued and admitted to trading on the respective stock exchange. Unless otherwise stated, capitalised terms in this announcement shall have the meanings given to them in the Circular dated 11 November 2020 in connection with the proposed Interim 2020 Dividend and Enhanced Scrip Dividend Alternative which can be found at: https://www.hammerson.com/investors/shareholderinformation/general-meeting.

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange.

 

Enquiries

Josh Warren, Head of Investor Relations

Tel: +44 20 7887 1053

josh.warren@hammerson.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVKKABBDBDDPBD
Date   Source Headline
7th May 20254:30 pmRNSTotal Voting Rights
7th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares
2nd May 20257:00 amRNSTransaction in Own Shares
1st May 20257:00 amRNSTransaction in Own Shares
30th Apr 202512:30 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNSTransaction in Own Shares
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20252:00 pmRNSTotal Voting Rights
22nd Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20254:40 pmRNSEMTN Programme: publication of Base Prospectus
15th Apr 20253:30 pmRNSTotal Voting Rights
15th Apr 20259:30 amRNSDividend Currency Conversion Announcement
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:01 amRNSTotal Voting Rights
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20253:30 pmRNSDirector/PDMR Shareholding
8th Apr 202512:30 pmRNSDirector/PDMR Shareholding
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20253:00 pmRNSTotal Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20252:30 pmRNSTotal Voting Rights
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20251:30 pmRNSDirector Declaration
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20251:00 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20253:45 pmRNSTotal Voting Rights
25th Mar 20253:00 pmRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20253:15 pmRNSTotal Voting Rights
18th Mar 20253:00 pmRNSDirector/PDMR Shareholding
18th Mar 202511:00 amRNSAnnual Report and Notice of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.